{
    "2021-01-05": [
        [
            {
                "time": "2021-01-04",
                "original_text": "AbbVie Outpaces Stock Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "outpaces",
                        "stock market gains"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-04",
                "original_text": "AbbVie Is a Stock to Position for 2021",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "position",
                        "2021"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-04",
                "original_text": "Risankizumab (SKYRIZIÂ®) Phase 3 Results Demonstrate Improvements in Disease Activity Across Joint and Skin Symptoms Among Psoriatic Arthritis Patients",
                "features": {
                    "keywords": [
                        "Risankizumab",
                        "SKYRIZI",
                        "Phase 3",
                        "improvements",
                        "disease activity",
                        "psoriatic arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-04",
                "original_text": "Got $1,000? These 2 Top Stocks Can Make You Rich",
                "features": {
                    "keywords": [
                        "$1,000",
                        "top stocks",
                        "rich"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}